OQS
ROIV icon

Occudo Quantitative Strategies’s Roivant Sciences ROIV Stock Holding History

Occudo Quantitative Strategies’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-64,858
Closed -$320K – 1349
2022
Q1 		$320K Buy
+64,858
New +$428K 0.03% 793

Other funds holding ROIV

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
PT
Palantir Technologies Denver, Colorado $9.72M AUM 6.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return

Occudo Quantitative Strategies's ROIV Position: Q2 2022 in Review

Occudo Quantitative Strategies sold out of Roivant Sciences (ROIV) in Q2 2022, closing a stake of 64,858 shares — an estimated $320K sold.

Occudo Quantitative Strategies first reported a position in ROIV in Q1 2022 and held it in 1 quarter. The position peaked at $320K in Q1 2022. 71 funds tracked by Wall St. Rank hold ROIV as of Q2 2022.

  • Occudo Quantitative Strategies reported no remaining Roivant Sciences position as of Q2 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 64,858 Roivant Sciences shares in Q2 2022, an estimated $320K.
  • Occudo Quantitative Strategies first reported a position in Roivant Sciences in Q1 2022 and held it in 1 quarter.
  • Occudo Quantitative Strategies's Roivant Sciences position peaked at $320K in Q1 2022.
  • 71 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.